BARBIERI, ANNA MARIA
BARBIERI, ANNA MARIA
Dipartimento di Scienze Cliniche e di Comunità
Preclinical evaluation of the antitumoral efficacy of Wee1 inhibitor AZD1775 in adrenocortical carcinoma
2025 E. Nozza, E. Emanuela, G. Di Muro, S. Di Bari, R. Catalano, G. Lopez, V. Vaira, A.M. Barbieri, G. Marra, M. Federica, T. Donatella, M. Battistin, Di Dalmazi Guido, S. Palmieri, F. Emanuele, G. Mantovani, E.M. Peverelli
Emerging role of IGF1R and IR expression and localisation in adrenocortical carcinomas
2025 R. Catalano, E. Nozza, B. Altieri, E. Esposito, G.A. Croci, A.M. Barbieri, D. Treppiedi, S. Di Bari, O. Kimpel, M. Detomas, M. Tamburello, M.P. Schauer, S. Herterich, A. Angelousi, M. Luconi, L. Canu, G. Nesi, C. Hantel, S. Sigala, L. Landwehr, G. Di Dalmazi, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, E. Ferrante, C.L. Ronchi, G. Mantovani, E. Peverelli
Therapeutic potential of targeting the FLNA‐regulated Wee1 kinase in adrenocortical carcinomas
2025 E. Esposito, G. Marra, R. Catalano, S. Maioli, E. Nozza, A.M. Barbieri, C. Hantel, G. Di Dalmazi, S. Sigala, J. Geginat, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, A. Berruti, E. Ferrante, G. Mantovani, E. Peverelli
Potential antitumoral effects of SRPK1 inhibition through modulation of VEGF splicing in pituitary somatotroph tumoral cells
2025 D. Treppiedi, S. Di Bari, F. Mangili, A.M. Barbieri, G. Di Muro, M. Locatelli, A. Mangone, E. Peverelli, G. Mantovani
Potential antitumoral effects through modulation of VEGF-A splicing in rat somatotroph and lactotroph pituitary tumoral cells
2024 D. Treppiedi, S. Di Bari, F. Mangili, G. Marra, A.M. Barbieri, F. Arlati, M. Locatelli, A. Lania, E. Peverelli, G. Mantovani
The novel SST3 agonist ITF2984 exerts antimitotic and proapoptotic effects in human non-functioning pituitary neuroendocrine tumor (NF-PitNET) cells
2024 G. Di Muro, R. Catalano, D. Treppiedi, A.M. Barbieri, F. Mangili, G. Marra, S. Di Bari, E. Esposito, E. Nozza, A. Lania, M. Locatelli, D. Modena, C. Steinkuhler, E. Peverelli, G. Mantovani
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells
2024 G. Di Muro, R. Catalano, D. Treppiedi, A.M. Barbieri, F. Mangili, G. Marra, S. Di Bari, E. Esposito, E. Nozza, A.G. Lania, E. Ferrante, M. Locatelli, D. Modena, C. Steinkuhler, E. Peverelli, G. Mantovani
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas
2024 E. Esposito/, R. Catalano, E. Nozza, G. Marra, S. Maioli, G. Dimuro, A.M. Barbieri, H. Constanze, G. Didalmazi, J.E. Geginat, E. Cassinotti, L. Baldari, S. Palmieri, A. Mangone, E. Ferrante, G. Mantovani, E. Peverelli
A β-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells
2023 G. Di Muro, F. Mangili, E. Esposito, A.M. Barbieri, R. Catalano, D. Treppiedi, G. Marra, E. Nozza, A.G.A. Lania, E. Ferrante, M. Locatelli, M. Arosio, E. Peverelli, G. Mantovani
IGF2R: a new player in the insulin-like growth factor 2 (IGF2) pathway sustaining adrenocortical carcinoma cells growth
2023 E. Nozza, R. Catalano, E. Esposito, A.M. Barbieri, G. Marra, D. Treppiedi, G. Di Muro, F. Mangili, H. Constanze, S. Sigala, S. Palmieri, S. Frigerio, E. Ferrante, M. Arosio, G. Mantovani, E. Peverelli
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells
2022 F. Mangili, E. Esposito, D. Treppiedi, R. Catalano, G. Marra, G. Di Muro, A.M. Barbieri, M. Locatelli, A.G. Lania, A. Mangone, A. Spada, M. Arosio, E. Peverelli, G. Mantovani
P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs
2022 D. Treppiedi, G. Marra, G. DI MURO, E. Esposito, A.M. Barbieri, R. Catalano, F. Mangili, F. Bravi, M. Locatelli, A. Gerardo Lania, E. Ferrante, R. Indirli, E. Nozza, F. Arlati, A. Spada, M. Arosio, G. Mantovani, E.M. Peverelli
TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 Infection
2022 D. Treppiedi, G. Marra, G. Di Muro, R. Catalano, F. Mangili, E. Esposito, A.M. Barbieri, M. Arosio, G. Mantovani, E. Peverelli
Adrenalectomy improves blood pressure and metabolic control in patients with possible autonomous cortisol secretion : results of a RCT
2022 V. Morelli, S. Frigerio, C. Aresta, E. Passeri, F. Pugliese, M. Copetti, A.M. Barbieri, S. Fustinoni, E. Polledri, S. Corbetta, M. Arosio, A. Scillitani, I. Chiodini
β-arrestin 2 is required for dopamine receptor type 2 inhibitory effects on AKT phosphorylation and cell proliferation in pituitary tumors
2021 F. Mangili, E. Giardino, D. Treppiedi, A.M. Barbieri, R. Catalano, M. Locatelli, A.G. Lania, A. Spada, M. Arosio, G. Mantovani, E. Peverelli
Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells
2021 D. Treppiedi, G. Di Muro, F. Mangili, R. Catalano, E. Giardino, A.M. Barbieri, M. Locatelli, M. Arosio, A. Spada, E. Peverelli, G. Mantovani
USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs
2021 D. Treppiedi, G. Di Muro, G. Marra, A.M. Barbieri, F. Mangili, R. Catalano, A. Serban, E. Ferrante, M. Locatelli, A.G. Lania, M. Arosio, A. Spada, E. Peverelli, G. Mantovani
Genetic profiling of a cohort of Italian patients with ACTH-secreting pituitary tumors and characterization of a novel USP8 gene variant
2021 D. Treppiedi, A.M. Barbieri, G. Di Muro, G. Marra, F. Mangili, R. Catalano, E. Esposito, E. Ferrante, A.L. Serban, M. Locatelli, A.G. Lania, A. Spada, M. Arosio, E. Peverelli, G. Mantovani
Octreotide and pasireotide effects on medullary thyroid carcinoma (MTC) cells growth, migration and invasion
2020 E. Giardino, R. Catalano, F. Mangili, A.M. Barbieri, D. Treppiedi, F.M. Elli, A. Dolci, A. Contarino, A. Spada, M. Arosio, G. Mantovani, E. Peverelli
Prediction of hypertension, diabetes and fractures in eucortisolemic women by measuring parameters of cortisol milieu
2020 V. Morelli, C. Aresta, A. Gaudio, C. Eller-Vainicher, V.V. Zhukouskaya, D. Merlotti, E. Orsi, A. Maria Barbieri, S. Fustinoni, E. Polledri, L. Gennari, A. Falchetti, V. Carnevale, L. Persani, A. Scillitani, I. Chiodini